Open Label Treprostinil Raynaud's Study
NCT07112183
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Raynaud's Disease
Raynaud Phenomena
Raynauds
Interventions
DRUG:
Oral treprostinil (UT-15C) sustained release tablets
Sponsor
Brigham and Women's Hospital